Renalytix to Present at Cowen 42nd Annual Health Care Conference
NEW YORK and SALT LAKE CITY, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (“Renalytix” or...
Month: February 2022
Otonomy Completes Enrollment in Phase 2 Clinical Trial of OTO-313 in Tinnitus
OTO-313 Phase 2 trial is fully enrolled ahead of scheduleTop-line results for all timepoints expected in mid-2022SAN DIEGO, Feb. 22,...
Zenith Epigenetics Announces Dosing of First Cancer Patient with a Combination of ZEN-3694 + Bristol Myers Squibb’s Immune Checkpoint Inhibitor OPDIVO
National Cancer Institute Sponsored Phase 1/1b clinical study to test combination of epigenetic and immune-oncology therapies in solid tumors and...
Elixxer Ltd. Announces Amended Secured Loan with AIP Convertible Private Debt Fund L.P.
Montreal, Quebec--(Newsfile Corp. - February 22, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased...
CENTR Ranked #1 Selling CBD Beverage in the United States by Brightfield Research
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
Halberd Medical Breakthrough for the Treatment of Neurodegenerative Diseases Affecting 36 Million Americans Annually
Jackson Center, Pennsylvania--(Newsfile Corp. - February 22, 2022) - Halberd Corporation (OTC Pink: HALB) has made a medical breakthrough in...
University Hospitals Ventures to Expand Collaboration with Lazurite™ and Invest in the Company
CLEVELAND--(BUSINESS WIRE)--#MinimallyInvasive--Medical device and technology company Lazurite Holdings LLC today announced a new phase of collaboration with University Hospitals (UH)...
CHA Accelerates Growth With Funding From Ironwood Investment Management
Relief for overloaded doctors and nurses, along with an expanding international clientele are timely factors BRAINTREE, Mass.--(BUSINESS WIRE)--A preliminary investment...
Signifier Medical Technologies is Granted HCPCS Codes for eXciteOSA to Help Patients Access Innovative Technology
CMS establishes new Level II HCPCS codes to describe eXciteOSA, the first-ever daytime treatment for obstructive sleep apnea BOSTON--(BUSINESS WIRE)--Signifier...
Next generation of surgical robotics now available in the Pacific Northwest
POST FALLS, Idaho, Feb. 22, 2022 /PRNewswire/ -- Orthopedic surgeons at Northwest Specialty Hospital in Post Falls, Idaho, are among the...
XPhyto Provides Progress Update on Psychedelic Medicine Programs and Novel Compounds Milestone
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 22, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022
CHESTER, N.Y.--(BUSINESS WIRE)--First paragraph, first sentence of release dated February 16, 2022, should read: Repro Med Systems, Inc. dba KORU...
Taconic Biosciences® Launches Cage+™, Redefining Colony Management Solutions for the Modern Laboratory
Stewardship Approach Safeguards All Elements of Contract Breeding ServicesRENSSELAER, N.Y., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global...
Annual General Meeting in ALK-Abelló A/S on 16 March 2022
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place...
TRIOSE Wins ‘Organization of The Year’ for Excellent Customer Service
National Customer Service Association’s 2022 All-Stars Awards honor logistics company NCSA 2022 Awards TRIOSE was awarded service organization of the...
ReWalk Robotics to Report Fourth Quarter 2021 Financial Results on February 24, 2022
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”...
Autolus Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on March 10
LONDON, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...
Ocugen to Host Conference Call on Friday, February 25 at 8:30 a.m. ET to Discuss Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update
MALVERN, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...
Ocugen, Inc. Announces U.S. FDA Lifts Clinical Hold on the Submission of Its Investigational New Drug Application for Its COVID-19 Vaccine Candidate COVAXIN™ (BBV152)
MALVERN, Pa., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing,...
Rhino Biotech Appoints New Interim Board of Directors to Initiate Rapid Growth of the Company
ANGUILLA, BWI / ACCESSWIRE / February 18, 2022 / Rhino Biotech Limited (OTC:RBRXF) formerly Eurasia Energy Limited (OTC:EUENF):Rhino Biotech Limited...